V. Vendrely

8.8k citations

161 papers · 3.4k indexed · 2 hit papers · h-index 28

Impact in

Oncology top 1%
- Colorectal Cancer Surgical Treatments
- Colorectal Cancer Screening and Detection
- Pancreatic and Hepatic Oncology Research
- Colorectal Cancer Treatments and Studies
Surgery top 1%
- Colorectal and Anal Carcinomas
- Anorectal Disease Treatments and Outcomes

Papers in ⓘ

Surgery 103
- Colorectal and Anal Carcinomas 82
Oncology 101
- Colorectal Cancer Surgical Treatments 64
- Colorectal Cancer Treatments and Studies 28
- Colorectal Cancer Screening and Detection 19
- Pancreatic and Hepatic Oncology Research 17

Co-authors: Éric Rullier (27 shared papers)Alexis Laurent (17 shared papers)Anne Rullier (17 shared papers)Quentin Denost (18 shared papers)Olivier Bouché (11 shared papers)Geneviève Belleannée (7 shared papers)Éric François (16 shared papers)Pierre-Luc Etienne (12 shared papers)
Journals: Journal of Clinical Oncology (26 papers)Annals of Oncology (10 papers)Radiotherapy and Oncology (10 papers)Digestive and Liver Disease (8 papers)International Journal of Radiation Oncology*Biology*Physics (7 papers)
Partner nations: France Canada Italy

In The Last Decade

V. Vendrely

147 papers receiving 3.4k citations

Hit Papers

align trajectories log scale

Total neoadjuvant therapy with mFOLFIRINOX versus preoperative chemoradiotherapy in patients with locally advanced rectal cancer: long-term results of the UNICANCER-PRODIGE 23 trial 2024 · 57 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2024 Annals of Oncology
2010 Journal of Clinical Oncology

Peers

Countries citing papers authored by V. Vendrely

Since Specialization

Citations

This map shows the geographic impact of V. Vendrely's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by V. Vendrely with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites V. Vendrely more than expected).

Fields of papers citing papers by V. Vendrely

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by V. Vendrely. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by V. Vendrely. The network helps show where V. Vendrely may publish in the future.

Co-authors

The 25 scholars most cited alongside V. Vendrely, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with V. Vendrely Line = papers co-authored together V. Vendrely links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 161 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Comparison of Two Neoadjuvant Chemoradiotherapy Regimens for Locally Advanced Rectal Cancer: Results of the Phase III Trial ACCORD 12/0405-Prodige 2 Journal of Clinical Oncology ·Jean‐Pierre Gérard, D. Azria, S. Gourgou-Bourgade, I. Martel-Laffay, Christophe Hennequin, Pierre-Luc Etienne, V. Vendrely, Éric François, Guy de La Roche, Olivier Bouché, X. Mirabel, Bernard Denis, Laurent Mineur, Jean-François Berdah, M.-A. Mahé, Y. Bécouarn, Olivier Dupuis, Gérard Lledo, C. Montoto-Grillot, Thierry Conroy Hit paper breakdown →	2010	537
2	Sphincter-Saving Resection for All Rectal Carcinomas Annals of Surgery ·Éric Rullier, Alexis Laurent, F. Bretagnol, Anne Rullier, V. Vendrely, Frank Zerbib	2005	246
3	Organ preservation for rectal cancer (GRECCAR 2): a prospective, randomised, open-label, multicentre, phase 3 trial The Lancet ·Éric Rullier, Philippe Rouanet, Jean‐Jacques Tuech, A. Valverde, Bernard Lelong, Michel Rivoire, Jean‐Luc Faucheron, Mehrdad Jafari, G. Portier, Bernard Meunier, Igor Sileznieff, Michel Prudhomme, Frédéric Marchal, Marc Pocard, Denis Pezet, Anne Rullier, V. Vendrely, Quentin Denost, Julien Asselineau, A. Doussau	2017	226
4	Low Rectal Cancer Diseases of the Colon & Rectum ·Éric Rullier, Quentin Denost, V. Vendrely, Anne Rullier, Alexis Laurent	2013	158
5	Lymph Nodes After Preoperative Chemoradiotherapy for Rectal Carcinoma: Number, Status, and Impact on Survival The American Journal of Surgical Pathology ·Anne Rullier, Alexis Laurent, Maylis Capdepont, V. Vendrely, Geneviève Belleannée, Paulette Bioulac‐Sage, Éric Rullier	2008	149
6	An evaluation of the accuracy of CT when determining resectability of pancreatic head adenocarcinoma after neoadjuvant treatment European Journal of Radiology ·Christophe Cassinotto, Juliette Cortade, Geneviève Belleannée, Bruno Lapuyade, Éric Terrebonne, V. Vendrely, Alexis Laurent, António Sá Cunha	2012	110
7	High Clinical Value of Liquid Biopsy to Detect Circulating Tumor Cells and Tumor Exosomes in Pancreatic Ductal Adenocarcinoma Patients Eligible for Up-Front Surgery Cancers ·Étienne Buscail, Catherine Alix‐Panabières, Pascaline Quincy, Thomas Cauvin, Alexandre Chauvet, Olivier Degrandi, Charline Caumont, Séverine Verdon, Isabelle Lamrissi, Isabelle Moranvillier, Camille Buscail, Marion Marty, Camille Laurent, V. Vendrely, François Moreau‐Gaudry, Aurélie Bedel, Sandrine Dabernat, L. Chiche	2019	103
8	Total neoadjuvant therapy with mFOLFIRINOX versus preoperative chemoradiation in patients with locally advanced rectal cancer: Final results of PRODIGE 23 phase III trial, a UNICANCER GI trial. Journal of Clinical Oncology ·Thierry Conroy, Najib Lamfichekh, Pierre-Luc Etienne, Emmanuel Rio, Éric François, Nathalie Mesgouez‐Nebout, V. Vendrely, Xavier Artignan, Olivier Bouché, D. Gargot, Valérie Boige, Nathalie Bonichon-Lamichhane, Christophe Louvet, Clotilde Morand, Christelle de la Fouchardière, Béata Juzyna, Éric Rullier, Frédéric Marchal, Florence Castan, Christophe Borg	2020	102
9	Locally Advanced Pancreatic Adenocarcinoma: Reassessment of Response with CT after Neoadjuvant Chemotherapy and Radiation Therapy Radiology ·Christophe Cassinotto, Amaury Mouries, Jean-Pierre Lafourcade, Éric Terrebonne, Geneviève Belleannée, Jean‐Frédéric Blanc, Bruno Lapuyade, V. Vendrely, Alexis Laurent, L. Chiche, Tristan Wagner, António Sá Cunha, Delphine Gaye, Hervé Trillaud, François Laurent, Michel Montaudon	2014	98
10	Circulating Tumor Cell Clusters: United We Stand Divided We Fall International Journal of Molecular Sciences ·Samuel Amintas, Aurélie Bedel, François Moreau‐Gaudry, Julian Boutin, Louis Buscail, Jean‐Philippe Merlio, V. Vendrely, Sandrine Dabernat, Étienne Buscail	2020	86
11	Impact of Colloid Response on Survival After Preoperative Radiotherapy in Locally Advanced Rectal Carcinoma The American Journal of Surgical Pathology ·Anne Rullier, Alexis Laurent, V. Vendrely, Brigitte Le Bail, Paulette Bioulac‐Sage, Éric Rullier	2005	77
12	Surgical Resection after Radiochemotherapy in Patients with Unresectable Adenocarcinoma of the Pancreas Journal of the American College of Surgeons ·António Sá Cunha, A. Rault, Alexis Laurent, Xavier Adhoute, V. Vendrely, Geneviève Béllannée, René Brunet, Denis Collet, Bernard Masson	2005	71
13	Gastric cancer: French intergroup clinical practice guidelines for diagnosis, treatments and follow-up (SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO) Digestive and Liver Disease ·Aziz Zaanan, Olivier Bouché, Léonor Benhaïm, Bruno Buecher, Nicolas Chapelle, Olivier Dubreuil, Nadim Farés, Victoire Granger, Christine Lefort, Johan Gagnière, Julie Meilleroux, A.-S. Baumann, V. Vendrely, Michel Ducreux, Pierre Michel	2018	66
14	CD63-GPC1-Positive Exosomes Coupled with CA19-9 Offer Good Diagnostic Potential for Resectable Pancreatic Ductal Adenocarcinoma Translational Oncology ·Étienne Buscail, Alexandre Chauvet, Pascaline Quincy, Olivier Degrandi, Camille Buscail, Isabelle Lamrissi, Isabelle Moranvillier, Charline Caumont, Séverine Verdon, Alain Brisson, Marion Marty, L. Chiche, Camille Laurent, V. Vendrely, François Moreau‐Gaudry, Aurélie Bedel, Sandrine Dabernat	2019	65
15	Total neoadjuvant therapy with mFOLFIRINOX versus preoperative chemoradiation in patients with locally advanced rectal cancer: 7-year results of PRODIGE 23 phase III trial, a UNICANCER GI trial. Journal of Clinical Oncology ·Thierry Conroy, Pierre-Luc Etienne, Emmanuel Rio, Ludovic Evesque, Nathalie Mesgouez‐Nebout, V. Vendrely, Xavier Artignan, Olivier Bouché, Alice Boilève, Matthieu Delaye, D. Gargot, Valérie Boige, Nathalie Bonichon-Lamichhane, Christophe Louvet, Christelle de la Fouchardière, Clotilde Morand, Veronica Pezzella, Éric Rullier, Florence Castan, Christophe Borg	2023	64
16	How Does Chemoradiotherapy Following Induction FOLFIRINOX Improve the Results in Resected Borderline or Locally Advanced Pancreatic Adenocarcinoma? An AGEO-FRENCH Multicentric Cohort Annals of Surgical Oncology ·Daniel Pietrasz, Olivıer Turrini, V. Vendrely, Antoine Simon, Olivia Hentic, Romain Coriat, Fabienne Portales, Bertrand Le Roy, Julien Taı̈eb, Nicolas Régenet, Diane Goèré, Pascal Artru, Jean‐Christophe Vaillant, F. Huguet, Alexis Laurent, Alain Sauvanet, Jean‐Robert Delpéro, Jean‐Baptiste Bachet, António Sá Cunha	2018	61
17	Total neoadjuvant therapy with mFOLFIRINOX versus preoperative chemoradiotherapy in patients with locally advanced rectal cancer: long-term results of the UNICANCER-PRODIGE 23 trial Annals of Oncology ·Thierry Conroy, Florence Castan, Pierre-Luc Etienne, E. Rio, Nathalie Mesgouez‐Nebout, Ludovic Evesque, V. Vendrely, Xavier Artignan, Olivier Bouché, D. Gargot, Valérie Boige, Nathalie Bonichon-Lamichhane, Christophe Louvet, Clotilde Morand, Christelle de la Fouchardière, Alice Boilève, Matthieu Delaye, Sophie Gourgou, Veronica Pezzella, Christophe Borg Hit paper breakdown →	2024	57
18	Resveratrol and capsaicin used together as food complements reduce tumor growth and rescue full efficiency of low dose gemcitabine in a pancreatic cancer model Cancer Letters ·V. Vendrely, Evelyne Peuchant, Étienne Buscail, Isabelle Moranvillier, Benoı̂t Rousseau, Aurélie Bedel, Aurélia Brillac, Hubert de Verneuil, François Moreau‐Gaudry, Sandrine Dabernat	2017	56
19	Impact of Tumor Response on Survival After Radiochemotherapy in Locally Advanced Rectal Carcinoma The American Journal of Surgical Pathology ·Anne Rullier, Alexis Laurent, Maylis Capdepont, V. Vendrely, Paulette Bioulac‐Sage, Éric Rullier	2010	51
20	Anal cancer: French Intergroup Clinical Practice Guidelines for diagnosis, treatment and follow-up (SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO, SNFCP) Digestive and Liver Disease ·Laurence Moureau-Zabotto, V. Vendrely, Laurent Abramowitz, Christophe Borg, Éric François, Diane Goèré, F. Huguet, D. Peiffert, Laurent Siproudhis, Michel Ducreux, Olivier Bouché	2017	46

About V. Vendrely

V. Vendrely is a scholar working on Surgery, Oncology, Pulmonary and Respiratory Medicine, Radiology, Nuclear Medicine and Imaging and Epidemiology, having authored 161 papers that have together received 3.4k indexed citations. Recurring topics across this work include Colorectal and Anal Carcinomas (82 papers), Colorectal Cancer Surgical Treatments (64 papers), Gastric Cancer Management and Outcomes (30 papers), Colorectal Cancer Treatments and Studies (28 papers), Colorectal Cancer Screening and Detection (19 papers), Pancreatic and Hepatic Oncology Research (17 papers), Advanced Radiotherapy Techniques (13 papers) and Radiation Therapy and Dosimetry (12 papers). The work is most often cited by research in Oncology (2.7k citations), Surgery (2.1k citations), Pulmonary and Respiratory Medicine (932 citations), Cancer Research (393 citations) and Radiology, Nuclear Medicine and Imaging (311 citations). V. Vendrely has collaborated with scholars based in France, Canada and Italy. Frequent co-authors include Éric Rullier, Alexis Laurent, Anne Rullier, Quentin Denost, Olivier Bouché, Geneviève Belleannée, Éric François, Pierre-Luc Etienne, Paulette Bioulac‐Sage and F. Bretagnol. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, Radiotherapy and Oncology, Digestive and Liver Disease and International Journal of Radiation Oncology*Biology*Physics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact